Source:http://linkedlifedata.com/resource/pubmed/id/15742337
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2005-4-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
103
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1761-2
|
pubmed:meshHeading |
pubmed-meshheading:15742337-Biopsy, Needle,
pubmed-meshheading:15742337-Humans,
pubmed-meshheading:15742337-Male,
pubmed-meshheading:15742337-Neoplasm Staging,
pubmed-meshheading:15742337-Palpation,
pubmed-meshheading:15742337-Predictive Value of Tests,
pubmed-meshheading:15742337-Prostatic Neoplasms
|
pubmed:year |
2005
|
pubmed:articleTitle |
Carcinoma core distribution in patients with palpable and nonpalpable prostate tumors.
|
pubmed:publicationType |
Editorial,
Comment
|